# ALUR (Allurion Technologies, Inc.) - SEC EDGAR Financial Statements

> Allurion Technologies, Inc. reported $12.60M in revenue and a net loss of $33.35M for the trailing twelve months ended March 31, 2026 (down 47.2% year over year), with a 52.7% gross margin and a -211.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/ALUR
- Markdown: https://convexityos.com/fundamentals/ALUR.md
- SEC CIK: 0001964979
- Reporting currency: USD
- Latest filing period: March 31, 2026
- Last synced: Nov 21, 2026, 05:12 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001964979&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $12.60M | -47.2% YoY |
| Operating Income | TTM | -$26.61M | -211.2% margin |
| Net Income | TTM | -$33.35M | -264.7% net margin |
| Diluted EPS | TTM | -$2.50 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Mar 31, 2026 | $5.06M | Total debt: $896K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Revenue** | $15.23M | $32.11M | $53.47M | $64.21M |
| Cost of Revenue | $5.66M | $10.61M | $11.97M | $13.48M |
| **Gross Profit** | $9.57M | $21.50M | $41.50M | $50.73M |
| Research & Development | $7.57M | $17.37M | $27.69M | $16.97M |
| Selling, General & Admin | $32.16M | $54.33M | $92.88M | $65.77M |
| Total Operating Expenses | $39.73M | $71.70M | $120.6M | $82.74M |
| **Operating Income** | -$30.16M | -$50.20M | -$79.08M | -$32.01M |
| **EBITDA** | -$29.17M | -$49.20M | -$78.33M | -$31.11M |
| Interest Expense | $0 | $2.26M | $10.57M | $4.43M |
| Income Before Tax | -$28.68M | -$6.48M | -$80.34M | -$37.60M |
| Income Tax Expense | $74K | $718K | $264K | $143K |
| **Net Income** | -$28.75M | -$7.20M | -$80.61M | -$37.74M |
| Basic EPS | -$3.81 | -$3.20 | -$1,287.97 | -$238.00 |
| **Diluted EPS** | -$3.81 | -$3.20 | -$1,287.97 | -$238.00 |
| Basic Shares Outstanding | 7.5M | 2.2M | 63.9K | 170.8K |
| Diluted Shares Outstanding | 7.5M | 2.2M | 63.9K | 170.8K |

### Income Statement (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $2.95M | $3.61M | $2.66M | $3.38M | $5.58M | $5.59M | $5.37M | $11.77M |
| Cost of Revenue | $1.72M | $2.00M | $1.35M | $882K | $1.42M | $3.06M | $2.26M | $2.77M |
| **Gross Profit** | $1.23M | $1.61M | $1.30M | $2.50M | $4.16M | $2.53M | $3.11M | $8.99M |
| Research & Development | $912K | $1.13M | $2.02M | $1.80M | $2.62M | $4.12M | $3.21M | $4.31M |
| Selling, General & Admin | $4.05M | $6.77M | $8.92M | $7.65M | $8.82M | $15.53M | $12.24M | $14.03M |
| Total Operating Expenses | $4.96M | $7.90M | $10.93M | $9.45M | $11.44M | $19.65M | $15.45M | $18.34M |
| **Operating Income** | -$3.73M | -$6.29M | -$9.63M | -$6.95M | -$7.28M | -$17.11M | -$12.34M | -$9.35M |
| **EBITDA** | -$3.56M | -$6.13M | -$9.36M | -$6.61M | -$7.08M | -$16.90M | -$12.13M | -$9.15M |
| Interest Expense | -- | -- | $0 | $0 | -- | $0 | $0 | $339K |
| Income Before Tax | -$6.07M | -$6.11M | -$11.88M | -$9.29M | -$1.41M | -$9.10M | $8.80M | -$8.26M |
| Income Tax Expense | $22K | -$73K | $9.0K | $43K | $95K | $508K | $69K | $65K |
| **Net Income** | -$6.09M | -$6.04M | -$11.88M | -$9.34M | -$1.50M | -$9.61M | $8.74M | -$8.32M |
| Basic EPS | -$0.46 | -- | -$1.53 | -$28.51 | -$0.31 | -- | $3.41 | -$96.66 |
| **Diluted EPS** | -$0.46 | -- | -$1.53 | -$28.51 | -$0.31 | -- | $3.40 | -$96.66 |
| Basic Shares Outstanding | 13.4M | -- | 7.8M | 327.8K | 4.8M | -- | 2.6M | 86.1K |
| Diluted Shares Outstanding | 13.4M | -- | 7.8M | 327.8K | 4.8M | -- | 2.6M | 86.1K |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5.41M | $15.38M | $38.04M | $7.68M |
| **Cash & Short-Term Investments** | $5.41M | $15.38M | $38.04M | $7.68M |
| Accounts Receivable, Net | $3.95M | $7.13M | $18.19M | $29.35M |
| Inventory | $2.67M | $3.40M | $6.17M | $3.87M |
| **Total Current Assets** | $12.79M | $27.16M | $64.82M | $43.38M |
| Property, Plant & Equipment, Net | $1.37M | $2.47M | $3.38M | $2.38M |
| Other Non-Current Assets | $663K | $1.11M | $505K | $2.71M |
| **Total Non-Current Assets** | $2.98M | $5.66M | $6.90M | $7.99M |
| **Total Assets** | $15.77M | $32.81M | $71.71M | $51.37M |
| Accounts Payable | $3.57M | $6.57M | $10.38M | $5.81M |
| Short-Term Debt | -- | $35.71M | $38.64M | $53.36M |
| **Total Current Liabilities** | $38.45M | $18.86M | $65.42M | $75.87M |
| Long-Term Debt | $0 | $35.71M | -- | $3.10M |
| Other Non-Current Liabilities | $385K | $17K | $7.51M | $2.55M |
| **Total Non-Current Liabilities** | $54.52M | $91.93M | $76.77M | $7.82M |
| **Total Liabilities** | $92.96M | $110.8M | $142.2M | $83.68M |
| **Total Debt (incl. Leases)** | $969K | $73.63M | $41.86M | $59.53M |
| Common Stock | $6.0K | $3.0K | $2.0K | $3.0K |
| Retained Earnings | -$251.0M | -$222.2M | -$212.8M | -$132.2M |
| Accumulated Other Comp. Income | $5.14M | -$8.37M | -$700K | -- |
| **Total Stockholders' Equity** | -$77.19M | -$77.98M | -$71.30M | -$32.31M |
| Total Equity | -$77.19M | -$77.98M | -$71.30M | -$32.31M |

### Balance Sheet (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5.06M | $5.41M | $6.14M | $12.72M | $20.41M | $15.38M | $28.65M | $19.26M |
| **Cash & Short-Term Investments** | $5.06M | $5.41M | $6.14M | $12.72M | $20.41M | $15.38M | $28.65M | $19.26M |
| Accounts Receivable, Net | $3.48M | $3.95M | $3.98M | $5.85M | $8.31M | $7.13M | $9.94M | $13.36M |
| Inventory | $2.06M | $2.67M | $3.67M | $3.77M | $3.35M | $3.40M | $4.57M | $4.79M |
| **Total Current Assets** | $11.30M | $12.79M | $14.60M | $23.49M | $33.17M | $27.16M | $44.83M | $40.30M |
| Property, Plant & Equipment, Net | $1.23M | $1.37M | $1.51M | $1.97M | $2.30M | $2.47M | $3.08M | $3.25M |
| Other Non-Current Assets | $633K | $663K | $953K | $997K | $1.08M | $1.11M | $507K | $510K |
| **Total Non-Current Assets** | $2.69M | $2.98M | $3.54M | $4.68M | $5.25M | $5.66M | $5.87M | $6.25M |
| **Total Assets** | $13.99M | $15.77M | $18.14M | $28.17M | $38.41M | $32.81M | $50.70M | $46.55M |
| Accounts Payable | $3.06M | $3.57M | $2.81M | $3.83M | $4.98M | $6.57M | $10.39M | $7.98M |
| Short-Term Debt | -- | -- | -- | -- | -- | $35.71M | -- | -- |
| **Total Current Liabilities** | $37.26M | $38.45M | $11.62M | $11.62M | $15.90M | $18.86M | $19.24M | $23.56M |
| Long-Term Debt | $0 | $0 | -- | $28.77M | $30.96M | $35.71M | $36.09M | $40.95M |
| Other Non-Current Liabilities | $265K | $385K | $816K | $926K | $717K | $17K | $9.87M | $5.61M |
| **Total Non-Current Liabilities** | $54.65M | $54.52M | $89.45M | $80.53M | $92.31M | $91.93M | $95.27M | $93.57M |
| **Total Liabilities** | $91.91M | $92.96M | $101.1M | $92.14M | $108.2M | $110.8M | $114.5M | $117.1M |
| **Total Debt (incl. Leases)** | $896K | $969K | $1.15M | $30.52M | $32.98M | $73.63M | $37.24M | $43.59M |
| Common Stock | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $3.0K | $7.0K | $5.0K |
| Retained Earnings | -$257.1M | -$251.0M | -$244.9M | -$233.0M | -$231.6M | -$222.2M | -$218.4M | -$209.4M |
| Accumulated Other Comp. Income | $6.13M | $5.14M | -$1.36M | $6.27M | $3.93M | -$8.37M | $2.89M | -$5.98M |
| **Total Stockholders' Equity** | -$77.91M | -$77.19M | -$82.93M | -$63.98M | -$69.79M | -$77.98M | -$64.79M | -$70.58M |
| Total Equity | -$77.91M | -$77.19M | -$82.93M | -$63.98M | -$69.79M | -$77.98M | -$64.79M | -$70.58M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Net Income | -$28.75M | -$7.20M | -$80.61M | -$37.74M |
| Depreciation & Amortization | $983K | $997K | $746K | $895K |
| Stock-Based Compensation | $3.15M | $3.06M | $8.36M | $437K |
| Change in Receivables | $844K | $8.98M | -$1.32M | -$22.82M |
| Change in Inventory | -$486K | $543K | -$3.71M | -$1.15M |
| Change in Payables | -$3.14M | -$3.92M | $4.66M | $3.32M |
| **Operating Cash Flow** | -$28.95M | -$42.30M | -$63.98M | -$46.98M |
| Capital Expenditure | -- | -$611K | -$1.61M | -$1.55M |
| **Free Cash Flow** | -- | -$42.91M | -$65.59M | -$48.53M |
| **Investing Cash Flow** | -- | -$611K | -$1.61M | -$1.55M |
| **Financing Cash Flow** | $18.97M | $20.21M | $95.99M | $30.54M |
| **Net Change in Cash** | -$9.98M | -$22.70M | $30.40M | -$17.99M |

### Cash Flow Statement (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$6.09M | -$6.04M | -$11.88M | -$9.34M | -$1.50M | -$9.61M | $8.74M | -$11.91M |
| Depreciation & Amortization | $171K | $165K | $267K | $346K | $203K | $219K | $215K | $197K |
| Stock-Based Compensation | $638K | $702K | $531K | $1.02M | $897K | $839K | $860K | $805K |
| Change in Receivables | $365K | -$1.39M | $865K | $2.25M | -$883K | $1.78M | $2.79M | $2.74M |
| Change in Inventory | $176K | $278K | $53K | -$839K | $22K | -$8.0K | -$463K | $684K |
| Change in Payables | -$347K | $673K | -$921K | -$484K | -$2.41M | -$3.35M | $1.93M | -$4.05M |
| **Operating Cash Flow** | -$3.22M | -$5.32M | -$6.54M | -$7.61M | -$9.47M | -$13.27M | -$11.46M | -$8.93M |
| Capital Expenditure | -- | -- | -- | -- | -- | $0 | -$72K | -$435K |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -$13.27M | -$11.54M | -$9.36M |
| **Investing Cash Flow** | -- | -- | -- | -- | -- | $0 | -$72K | -$435K |
| Common Stock Issued | -- | -- | -- | -- | $14.50M | -- | -- | $0 |
| **Financing Cash Flow** | $2.87M | $4.60M | -$55K | -$71K | $14.50M | -$53K | $20.93M | -$1.06M |
| **Net Change in Cash** | -$355K | -$723K | -$6.60M | -$7.68M | $5.03M | -$13.33M | $9.40M | -$10.42M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Gross Margin** | 62.8% | 67.0% | 77.6% | 79.0% |
| **Operating Margin** | -198.0% | -156.3% | -147.9% | -49.9% |
| **Net Profit Margin** | -188.8% | -22.4% | -150.8% | -58.8% |
| Return on Assets (ROA) | -182.3% | -21.9% | -112.4% | -73.5% |
| Current Ratio | 0.33x | 1.44x | 0.99x | 0.57x |
| Quick Ratio | 0.26x | 1.26x | 0.90x | 0.52x |
| **Revenue Growth (YoY)** | -52.6% | -39.9% | -16.7% | -- |
| Gross Profit Growth (YoY) | -55.5% | -48.2% | -18.2% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 52.7% | 62.8% | 61.0% | 61.8% | 66.4% | 67.0% | 73.1% | 76.2% |
| **Operating Margin** | -211.2% | -198.0% | -238.1% | -219.4% | -162.8% | -156.3% | -169.2% | -152.6% |
| **Net Profit Margin** | -264.7% | -188.8% | -187.9% | -58.8% | -37.8% | -22.4% | -48.3% | -99.1% |
| Return on Assets (ROA) | -238.3% | -182.3% | -178.2% | -41.6% | -27.8% | -21.9% | -33.1% | -101.3% |
| Current Ratio | 0.30x | 0.33x | 1.26x | 2.02x | 2.09x | 1.44x | 2.33x | 1.71x |
| Quick Ratio | 0.25x | 0.26x | 0.94x | 1.70x | 1.88x | 1.26x | 2.09x | 1.51x |
| **Revenue Growth (YoY)** | -47.2% | -35.4% | -50.5% | -71.3% | -40.5% | -32.1% | -70.5% | -9.2% |
| Gross Profit Growth (YoY) | -70.5% | -36.5% | -58.1% | -72.2% | -39.4% | -60.6% | -77.7% | -9.8% |
| **Net Income Growth (YoY)** | -- | -- | -236.0% | -- | -175.2% | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -144.9% | -- | -100.5% | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
